Sign in

CIK 0000920148

  • Large accelerated filer

LABCORP HOLDINGS INC.

Sign in to watch
Ticker
LH
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Entity type
Operating
EIN
992588107
Phone
+1 336-229-1127
Business address
358 S MAIN ST, BURLINGTON, NC, 27215
Former names
LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,377,699
in 4 filings, $108K under 10b5-1 plans

Net −$1,377,699. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-11 Summy Amy B. EVP, Chief Marketing Officer Exercise or conversion +201 4,152
2024-02-11 Summy Amy B. EVP, Chief Marketing Officer Exercise or conversion · Restricted Stock Unit −201 7,095
2024-02-11 van der Vaart Sandra D EVP, Chief Legal Officer Exercise or conversion +324 7,960.98
2024-02-11 van der Vaart Sandra D EVP, Chief Legal Officer Exercise or conversion · Restricted Stock Unit −324 8,348
2024-02-11 Wilkinson Peter J SVP, Chief Accounting Officer Exercise or conversion +123 2,384.22
2024-02-11 Wilkinson Peter J SVP, Chief Accounting Officer Exercise or conversion · Restricted Stock Unit −123 3,870
2024-02-08 van der Vaart Sandra D EVP, Chief Legal Officer Sale 10b5-1 −259 $222.06 $58K 7,636.98
2024-02-07 Schechter Adam H President & CEO Exercise or conversion +3,250 52,410
2024-02-07 Schechter Adam H President & CEO Shares withheld for taxes −1,149 $223.71 $257K 51,261
2024-02-07 Schechter Adam H President & CEO Exercise or conversion · Restricted Stock Unit −3,250 98,241
2024-02-07 EISENBERG GLENN A Chief Financial Officer, EVP Exercise or conversion +885 43,689
2024-02-07 EISENBERG GLENN A Chief Financial Officer, EVP Shares withheld for taxes −236 $223.71 $53K 43,453
2024-02-07 EISENBERG GLENN A Chief Financial Officer, EVP Exercise or conversion · Restricted Stock Unit −885 36,546
2024-02-07 DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Exercise or conversion +224 3,739.55
2024-02-07 DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Shares withheld for taxes −78 $223.71 $17K 3,661.55
2024-02-07 DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Exercise or conversion +138 3,799.55
2024-02-07 DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Shares withheld for taxes −41 $223.71 $9K 3,758.55
2024-02-07 DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Exercise or conversion · Restricted Stock Unit −224 5,316
2024-02-07 DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Exercise or conversion · Restricted Stock Unit −138 5,178
2024-02-07 Caveney Brian J EVP, Pres of ED, CMO & CSO Exercise or conversion +517 21,143.04

Page 29 of 41 · 816 trades